COMMUNIQUÉS West-GlobeNewswire

-
Webinaire KOL Investisseurs d’OSE Immunotherapeutics : le paysage thérapeutique et les besoins médicaux non satisfaits dans le cancer du poumon non à petites cellules
12/06/2024 - 18:00 -
AAPS Calls for Overruling Jacobson v. Massachusetts, upon Which Vaccine Mandates Are Based
12/06/2024 - 16:16 -
Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT
12/06/2024 - 15:10 -
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
12/06/2024 - 15:05 -
Cute Season on Parliament Hill – Announcing the Winners of the 2nd Annual Cutest Pets on Parliament Hill Contest
12/06/2024 - 15:00 -
C’est la saison des animaux les plus mignons sur la Colline du Parlement - Annonce des gagnants du 2e concours annuel « Les animaux de compagnie les plus mignons sur la Colline du Parlement »
12/06/2024 - 15:00 -
Verana Health Committed to Revolutionizing Clinical Trials with Enhancements to SaaS Applications
12/06/2024 - 15:00 -
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
12/06/2024 - 15:00 -
BioSyent In-Licenses Endocrinology Product for Canada
12/06/2024 - 15:00 -
Precipio Provides Status Update on Current Business Matters
12/06/2024 - 15:00 -
Philips launches Duo Venous Stent System for treatment of symptomatic venous outflow obstruction
12/06/2024 - 15:00 -
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
12/06/2024 - 14:30 -
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
12/06/2024 - 14:30 -
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
12/06/2024 - 14:30 -
Streamline Health® Reports Fiscal First Quarter 2024 Financial Results
11/06/2024 - 22:30 -
Voting Rights and Shares Capital of the Company
11/06/2024 - 22:15 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
11/06/2024 - 22:15 -
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
11/06/2024 - 22:05 -
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11/06/2024 - 22:05
Pages